Concepedia

Kazuharu Kamachi

KK

Statistics

Publications

10

Citations

213

H-Index

10

Active since

2017

Affiliations

Saga University(Current)

Kyoto University

Takamatsu Red Cross Hospital

Kumamoto University

Tokyo University of Pharmacy and Life Sciences

Kazuharu Kamachi is an author at Saga University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2017–2023

10

Publications

10

Clinical impact of the CONUT score in patients with multiple myeloma

Sho Okamoto, Hiroshi Ureshino, Keisuke Kidoguchi et al. · Annals of Hematology · 2019 · 52 citations

, , +10

Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100

Tatsuro Watanabe, Satoshi Yamashita, Hiroshi Ureshino et al. · Blood · 2020 · 49 citations · Full text

, , +14

Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL

Yuki Kurahashi, Tatsuro Watanabe, Yuta Yamamoto et al. · Blood Advances · 2022 · 20 citations · Full text

, , +17

Targeting DNMT1 by demethylating agent OR-2100 increases tyrosine kinase inhibitors-sensitivity and depletes leukemic stem cells in chronic myeloid leukemia

Kazuharu Kamachi, Hiroshi Ureshino, Tatsuro Watanabe et al. · Cancer Letters · 2021 · 16 citations · Full text

, , +17

Adult T‐cell leukemia‐lymphoma acquires resistance to <scp>DNA</scp> demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism

Nao Yoshida‐Sakai, Tatsuro Watanabe, Yuta Yamamoto et al. · International Journal of Cancer · 2021 · 15 citations · Full text

, , +15

1–5 of 10